🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

1,061 notícias encontradas para "multi"
Adenotonsillectomy linked to increased odds of pediatric-onset multiple sclerosis
History of adenotonsillectomy is associated with increased odds of pediatric-onset multiple sclerosis (POMS), according to a study published online May 29 in Multiple Sclerosis Journal.
Foto: Anna Tarazevich / Pexels
Bacteria's 'mix-and-match' code could create new cancer-fighting drugs
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies. The breakthrough could accelerate the development of new treatm
Foto: Ian Taylor / Pexels
Genetic differences affecting toddler activity levels are also associated with ADHD
A toddler's activity levels are influenced by genetic differences, with some of the same genetic markers also linked to attention-deficit/hyperactivity disorder (ADHD), according to new research from the University of Surrey. In the first study of its kind, an international team
Investigators report promising results from Phase II trial of targeted therapy for rare bi
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p
Foto: Google DeepMind / Pexels
Identification of new molecular markers for multiple myeloma paves path for more precise t
Researchers at Cima and Clinica Universidad de Navarra have identified new molecular mechanisms underlying multiple myeloma. This type of hematologic cancer, which affects the bone marrow, is characterized by its resistance to treatment, leading to relapses in patients. The resea
'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial
A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers showed. The findings, publis
Obesidade: o que a ciência já sabe
Obesidade: o que a ciência já sabe
Entenda por que a obesidade é uma doença crônica multifatorial e o que metabolismo, cérebro e exercício revelam. Veja o que a ciência indica
Repurposed cancer drug rapidly eased rare autoimmune neuropathy in two patients
An interdisciplinary team at Jena University Hospital achieved a surprisingly rapid and significant improvement in two patients with an autoimmune peripheral nervous system disorder. The team administered teclistamab, a drug originally developed for multiple myeloma, and reported
Foto: Merlin Lightpainting / Pexels
AI unlocks previously invisible cortical lesions in MS using legacy MRI scans
One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.
Multimorbidity highly prevalent among older Australians, clustering into three distinct ty
A new nationwide study from the University of Sydney analyzed the health records of more than 4.4 million older Australians (65 years and over) and found that more than three-quarters are living with multiple chronic conditions, and that these conditions tend to cluster into thre
Quem é o brasileiro que correu mais de 200km em 24 horas?
Quem é o brasileiro que correu mais de 200km em 24 horas?
Guarda-vidas, Flávio Henrique Pinto dos Santos, de 43 anos, superou Recorde do Guinness Book, no litoral paulista O recorte ajuda a contextualizar a pauta dentro de Fitness.
Foto: Michelle Leman / Pexels
Largest study yet reveals which cancers have their own microbiomes
For decades, cancer has been thought of as a purely human disease—rogue cells multiplying out of control, with no room for anything else in the picture. But a growing body of research suggests that isn't quite right. Some tumors, it turns out, come with company: communities of ba